Cloverdale Capital Management Portfolio holdings
Top Buys
| 1 |
Addus HomeCare
ADUS
|
+$24.4M |
| 2 |
Lantheus
LNTH
|
+$13.6M |
| 3 |
CUTR
Cutera, Inc.
CUTR
|
+$6.59M |
| 4 |
Regional Management Corp
RM
|
+$4.01M |
| 5 |
Kontoor Brands
KTB
|
+$2.87M |
Top Sells
| 1 |
U-Haul Holding Co
UHAL
|
+$10.8M |
| 2 |
CRCM
CARE.COM, INC.
CRCM
|
+$10.4M |
| 3 |
PRSP
Perspecta Inc. Common Stock
PRSP
|
+$9.44M |
| 4 |
CLDR
Cloudera, Inc.
CLDR
|
+$7.32M |
| 5 |
Barrett Business Services
BBSI
|
+$6.38M |
Sector Composition
| 1 | Technology | 39.45% |
| 2 | Healthcare | 30.31% |
| 3 | Consumer Discretionary | 12.13% |
| 4 | Industrials | 10.18% |
| 5 | Financials | 2.86% |
Similar funds
Cloverdale Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Cloverdale Capital Management held 21 positions worth $148M, up 1.3% from $146M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Cloverdale Capital Management deployed $5.16M of net new capital in Q3 2019, opening 8 new positions and adding to 3 existing holdings. Its largest new stake was Addus HomeCare: 301,500 shares worth $23.9M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 52% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Perspecta Inc. Common Stock, an estimated $9.44M trimmed.
- Cloverdale Capital Management's largest Q3 2019 buy was Addus HomeCare: 301,500 shares worth $23.9M.
- Cloverdale Capital Management added most to Box in Q3 2019, an estimated $2.22M increase.
- Cloverdale Capital Management's biggest Q3 2019 reduction was Perspecta Inc. Common Stock, cutting an estimated $9.44M.
- Cloverdale Capital Management fully exited U-Haul Holding Co in Q3 2019, selling an estimated $10.8M.
- Cloverdale Capital Management's ten largest holdings make up 89% of its $148M portfolio in Q3 2019.
- Cloverdale Capital Management opened 8 new positions and closed 5 in Q3 2019.
- Cloverdale Capital Management's portfolio value rose 1.3% quarter-over-quarter to $148M.
Based on Cloverdale Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.